[ad_1]
Coway Co., a number one South Korean residence equipment maker, stated on Jan. 27 that it has launched a brand new residence medical machine model, Therasol. The model’s debut product is the Therasol U, a medical machine designed to deal with urinary incontinence.
The title Therasol is a portmanteau of “remedy” and “resolution,” reflecting the corporate’s intention to handle buyer well being via specialised residence care.
Urinary incontinence is a serious situation affecting middle-aged and older adults. In response to the Well being Insurance coverage Evaluate and Evaluation Service, about 95 % of sufferers with stress urinary incontinence are aged 40 or older, and the variety of sufferers has been rising quickly as inhabitants getting older accelerates.
Coway believes demand for home-care options within the urinary incontinence remedy market is especially robust. Whereas discomfort amongst middle-aged and older adults continues to extend, many sufferers are reluctant to go to hospitals as a result of delicate nature of the situation, leading to a comparatively low fee of precise medical remedy. In opposition to this backdrop, Therasol U was designed to maximise the advantages of residence care by delivering results just like Kegel workouts via merely sitting on the machine for quarter-hour a day.
The machine enhances remedy effectiveness by repeatedly contracting and stress-free muscle groups utilizing low-frequency electrical stimulation. Outfitted with six stimulation factors and a three-pair channel construction, Therasol U delivers stimulation to surrounding areas, whereas depth ranges may be finely adjusted throughout 99 phases.
Beginning with Therasol U, Coway plans to enter the senior healthcare market in earnest and increase its product lineup.
[ad_2]
